Nature Biotechnology 25, 485–486 (2007); published online 6 April 2007
In the version of this article originally published, the performance of the UK Medical and Healthcare Products Regulatory Agency (MHRA) is described in the sentence of the penultimate paragraph in the 2nd column on p. 486 as follows: “As the BIA points out, that would make the entire CTA process take an absolute minimum of 11 weeks.” According to MHRA, however, this is wholly incorrect and completely exaggerates the time taken. Full assessments of time-based performance of MHRA can be found at: http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=1083.
Additional information
The online version of the original article can be found at 10.1038/nbt0507-485
Rights and permissions
About this article
Cite this article
Mitchell, P. Erratum: Critics pan timid European response to TeGenero disaster. Nat Biotechnol 25, 1057 (2007). https://doi.org/10.1038/nbt0907-1057a
Issue Date:
DOI: https://doi.org/10.1038/nbt0907-1057a
